SquamousCellCarcinomaofSkin near Largo, FL

Care Philosophy: Dr. Fletcheris an Associate Professor of Medicine within the Division of Hematology and Oncology. He is a Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee.

Care Philosophy: Dr Zhang is a Genitourinary Oncologist and Interim Vice Chair of the Department of Genitourinary Oncology at Moffitt Cancer Center. He is also an Associate Professor of Oncology and Internal Medicine at the University of South Florida College of Medicine. His primary research interest is in integrating tumor evolution dynamics into the treatment for advanced prostate cancer. As the clinical research Director of Moffitt Cancer Center's Genitourinary Oncology Department, he has been the Principal Investigator (PI) and Co-Investigator of more than 50 phase I, II, and III clinical studies since joining Moffitt in July 2010.

Biography: Dr. Richard Tuli, MD is a Radiation Oncology Specialist who practices in Tampa, FL. He is 50 years old. Dr. Richard Tuli, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Biography: Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. Fluent in English and Spanish, Dr. Sotomayor specializes in the treatment of lymphomas and leukemias. The accomplished physician-scientist's ongoing research is directed toward cancer immunology and immunotherapy with special focus in developing novel immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Considered as a world expert in mantle cell lymphoma (MCL), he has more than 140 publications including seminal discoveries published in top tier journals such as Nature Immunology, Nature Medicine, Blood, Proceedings of the National Academy of Sciences, Cancer Cell among others. He has been the recipient of several awards, including the recipient of the National Cancer Institute (NCI) CURE Lifetime Achievement award in 2017. Dr. Sotomayor is involved in several major medical societies and organizations and currently is a member of the Scientific Advisory Board, Lymphoma Research Foundation, member of the Executive Committee of the Mantle Cell Lymphoma Consortium and member of several committees of the American Association for Cancer Research (AACR). He has also served in committees at the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI)

Care Philosophy: Dr Christine Sam is an Assistant Member in the Department of Individualized Cancer Management/Senior Adult Oncology Program. Dr Sam received her medical degree from Michigan State University College of Human Medicine in East Lansing. She completed an Internal Medicine Residency at University of Michigan Health Systems in Ann Arbor. She completed her Hematology and Medical Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine in Tampa. Dr Sam's primary clinical interest is the treatment of cancer in older patients and developing care plans tailored to their individual needs. Her focus is the treatment of breast, gastrointestinal, and genitourinary malignancies.

Care Philosophy: Dr Blue earned his MD at Meharry Medical College, Nashville, Tennessee. Dr Blue completed an Internal Medicine Residency in the Department of Medicine at Washington University School of Medicine, St. Louis, Missouri, and d a Hematology/Oncology Fellowship in the Department of Medicine at Saint Louis University School of Medicine. Dr Blue recently completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. Dr Blue's clinical interests include treatment of plasma cell disorders and evaluation of patients pre and post bone marrow transplant. His research interests include reducing health disparities and improving health outcomes for plasma cell dyscrasias.

Care Philosophy: Dr Pinilla-Ibarz has been at Moffitt since 2006 and holds the rank of Senior Member and Head of Lymphoma Section in the Department of Malignant Hematology. Dr Pinilla-Ibarz received the 2016-17 Moffitt Physician of the Year Award. He was also the recipient of the ASCO young investigator award in 2003 and the ASCO career development award in 2007. Dr Pinilla-Ibarz is nationally and internationally known for his expertise in chronic leukemia and he currently has over 120 peer-reviewed publications. He has received grant support through the Leukemia & Lymphoma Society and also from multiple industry partners. His clinical interests include chronic myeloid leukemia and chronic lymphoid leukemia.

Care Philosophy: Dr Druta earned her MD degree from the University of Medicine and Pharmacy Carol Davila, Romainia. She completed an Internal Medicine Residency and Hematology/Medical Oncology Fellowship at the University of South Florida at Moffitt Cancer Center. Dr Druta most recently completed a Sarcoma Medical Oncology Fellowship (Willie Tichenor Sarcoma Fellowship) at MD Anderson Cancer Center. Dr Druta's clinical interest is in the development of clinical trials focusing on targeted therapeutics specific to sarcoma patients. Her research interest is in the translational aspects of sarcoma biology focusing specifically on Well-differentiated/Differential Liposarcoma and Leiomyosarcoma.

Care Philosophy: Dr Shafique earned his Medical Degree from the University of Virginia School of Medicine and completed an Internal Medicine residency at Duke University Medical Center and a subsequent Hematology and Medical Oncology fellowship at the University of South Florida/Moffitt Cancer Center. Although Dr Shafique devotes most of his time to treating patients with lung cancer, he also sees patients with a broad spectrum of diagnoses as part of early-phase clinical trials. Additionally, he manages medical oncology treatments for patients with Gynecologic malignancies.

Care Philosophy: Dr Sameh Gaballa is an AssociateMember in the Moffitt Cancer Center Department of Malignant Hematology. Dr Gaballa earned his MD from Aims Shams University in Cairo, Egypt. He completed an Internal Medicine Residency and a Hematology and Medical Oncology Fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. He then completed a Stem Cell Transplantation and Cellular Therapy Fellowship at the University of Texas MD Anderson Cancer Center. Dr Gaballa previously practiced in the Thomas Jefferson University, Division of Hematologic Malignancies and Blood and Marrow Transplantation.